Skip to main content
SNSE
NASDAQ Life Sciences

Major Shareholder Files Intent to Sell $4.95M in Sensei Biotherapeutics Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$27.655
Mkt Cap
$37.065M
52W Low
$5.25
52W High
$36.76
52W Position info
427% above low
Off High info
25% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SNSE has more than doubled off its 52-week low of $5.25 on light trading volume (0.1× avg).

Summary

A 10% owner, Cambrian BioPharma Inc, has filed a Form 144 indicating intent to sell 155,142 shares of Sensei Biotherapeutics common stock, valued at approximately $4.95 million, amidst ongoing corporate restructuring.


Key Events · Ownership and Investor Activity · SNSE

  • Major Shareholder Intent to Sell

    Cambrian BioPharma Inc, identified as a 10% stockholder, filed a Form 144 to sell 155,142 shares of common stock.

  • Significant Transaction Value

    The proposed sale is valued at approximately $4.95 million, representing over 13% of the company's current market capitalization.

  • Context of Corporate Restructuring

    This intent to sell occurs shortly after an S-3 registration for the resale of up to 24.87 million shares and amidst recent proxy filings detailing a 'massive recapitalization' and potential reverse stock split.


Analysis · SNSE · Life Sciences

Cambrian BioPharma Inc, a 10% stockholder, has filed a Form 144 indicating intent to sell 155,142 shares of Sensei Biotherapeutics common stock, valued at approximately $4.95 million. This proposed sale represents a significant portion of the company's market capitalization and suggests a substantial reduction in the major shareholder's stake. The timing is notable as it follows closely on the heels of an S-3 registration for the resale of up to 24.87 million shares and ongoing efforts for a 'massive recapitalization' and potential reverse stock split, adding to potential market overhang and dilution concerns.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SNSE was trading at $27.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $37.1M. The 52-week trading range was $5.25 to $36.76. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SNSE - Latest Insights

SNSE
Jun 26, 2026, 7:40 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $13.85
Real-time Price: $13.85 info
Change: $0 (0%) info
Market Cap: $18.586M info
SNSE
Jun 24, 2026, 6:58 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $13.85
Real-time Price: $13.85 info
Change: $0 (0%) info
Market Cap: $18.586M info
SNSE
Jun 24, 2026, 6:55 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $13.85
Real-time Price: $13.85 info
Change: $0 (0%) info
Market Cap: $18.586M info
SNSE
Jun 18, 2026, 5:13 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $13.85
Real-time Price: $13.85 info
Change: $0 (0%) info
Market Cap: $18.586M info
SNSE
Jun 18, 2026, 4:01 PM EDT
Filing Type: S-3ASR
Importance Score:
9
Price at Filing: $13.85
Real-time Price: $13.85 info
Change: $0 (0%) info
Market Cap: $18.586M info